menu search

MacroGenics to Present at the 41st Annual J.P. Morgan Healthcare Conference

MacroGenics to Present at the 41st Annual J.P. Morgan Healthcare Conference
ROCKVILLE, MD, Jan. 04, 2023 (GLOBE NEWSWIRE) — MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing and commercializing innovative antibody-based therapeutics for the treatment of cancer, today announced that the company will participate in the 41st Annual J.P. Morgan Healthcare Conference. Scott Koenig, M.D., Ph.D., President & Chief Executive Officer of MacroGenics, […] The post MacroGenics to Present at the 41st Annual J.P. Morgan Healthcare Conference appear... Read More
Posted: Jan 4 2023, 22:50
Author Name: forextv
Views: 112522

Search within

Pages Search Results: